Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Do beta-tubulin pseudogenes really matter?

Cristobal Belda-Iniesta, Rosario Perona, Javier de Castro Carpeno

The Lancet. Oncology

|May 4, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Theranostics·2026

Same author

Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny.

The Journal of clinical investigation·2026

Same author

Whole-genome doubling drives immune evasion by silencing antigen presentation.

Cancer cell·2026

Same author

Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors.

Cancer treatment reviews·2026

Same author

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Cancer immunology, immunotherapy : CII·2026